Received Jan 6, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTPPVHBHPB | DTAP+IPV+HIB+HEPB (VAXELIS) | MSP VACCINE COMPANY | UNK | — | — |
| HEPA | HEP A (VAQTA) | MERCK & CO. INC. | UNK | — | — |
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | Y013818 | — |
| RV5 | ROTAVIRUS (ROTATEQ) | MERCK & CO. INC. | UNK | — | OT |
No additional AE/No PQC; Medical assistant reported administration of improperly stored vaccines; This spontaneous report was received from a physician and refers to a 9-year-old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 18-Oct-2025, the patient was vaccinated with Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL®9), lot #Y013818 was verified to be a valid lot number, expiration date: 12-Feb-2027, administered at dose of 0.5 mL for prophylaxis. On an unspecified date of 2025 (administrations were reported as beginning on 02-Oct-2025), the patient was vaccinated with; with Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ), administered by oral route for prophylaxis (lot # and expiration date were not reported); with Hepatitis A Vaccine, Inactivated (VAQTA), administered for prophylaxis (lot # and expiration date were not reported and with Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed, Inactivated Poliovirus (VAXELIS), (indication, expiration date, and lot # were not reported). The vaccines administered were reported as improperly stored (Improper storage of product in use). No additional adverse events were reported (no adverse event).; Sender's Comments: Priority : 4 , Is case serious : No , Index user : , Index date : 2025-12-16 , MNSC number : , CLIC number : , ESTAR number : , IRMS number : Central date : 2025-12-11 , Classification : DMC, Attachment description : Minimal Data Entry , Safety case number :